230 related articles for article (PubMed ID: 35443657)
1. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies.
Wong AW; Koo J; Ryerson CJ; Sadatsafavi M; Chen W
BMC Pulm Med; 2022 Apr; 22(1):148. PubMed ID: 35443657
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States.
Lee TY; Slejko JF; Davies-Teye BB; Onukwugha E
J Manag Care Spec Pharm; 2022 Jul; 28(7):786-794. PubMed ID: 35737860
[No Abstract] [Full Text] [Related]
3. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
Frank AL; Kreuter M; Schwarzkopf L
Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
[TBL] [Abstract][Full Text] [Related]
4. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
Mac S; da Silva SR; Sander B
PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
[TBL] [Abstract][Full Text] [Related]
6. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
Seuring T; Archangelidi O; Suhrcke M
Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
[TBL] [Abstract][Full Text] [Related]
7. The clinical and economic burden of systemic sclerosis related interstitial lung disease.
Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hansen D; Patel S; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
Rheumatology (Oxford); 2020 Aug; 59(8):1878-1888. PubMed ID: 31740961
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review.
Mattap SM; Mohan D; McGrattan AM; Allotey P; Stephan BC; Reidpath DD; Siervo M; Robinson L; Chaiyakunapruk N
BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35379735
[TBL] [Abstract][Full Text] [Related]
9. Cost of Lung Cancer: A Systematic Review.
Yousefi M; Jalilian H; Heydari S; Seyednejad F; Mir N
Value Health Reg Issues; 2023 Jan; 33():17-26. PubMed ID: 36201970
[TBL] [Abstract][Full Text] [Related]
10. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
[TBL] [Abstract][Full Text] [Related]
11. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
[TBL] [Abstract][Full Text] [Related]
12. Costs of multimorbidity: a systematic review and meta-analyses.
Tran PB; Kazibwe J; Nikolaidis GF; Linnosmaa I; Rijken M; van Olmen J
BMC Med; 2022 Jul; 20(1):234. PubMed ID: 35850686
[TBL] [Abstract][Full Text] [Related]
13. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
14. The Economic Burden of Bronchiectasis: A Systematic Review.
Roberts JM; Goyal V; Kularatna S; Chang AB; Kapur N; Chalmers JD; Goeminne PC; Hernandez F; Marchant JM; McPhail SM
Chest; 2023 Dec; 164(6):1396-1421. PubMed ID: 37423293
[TBL] [Abstract][Full Text] [Related]
15. The Economic Costs of Childhood Disability: A Literature Review.
Shahat ARS; Greco G
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33805375
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
[TBL] [Abstract][Full Text] [Related]
17. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
18. Cost of adult chronic rhinosinusitis: A systematic review.
Smith KA; Orlandi RR; Rudmik L
Laryngoscope; 2015 Jul; 125(7):1547-56. PubMed ID: 25640115
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe.
Seidl E; Schwerk N; Carlens J; Wetzke M; Cunningham S; Emiralioğlu N; Kiper N; Lange J; Krenke K; Ullmann N; Krikovszky D; ; Maqhuzu P; Griese CA; Schwarzkopf L; Griese M
Thorax; 2022 Aug; 77(8):781-789. PubMed ID: 35149583
[TBL] [Abstract][Full Text] [Related]
20. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013.
Soliman AM; Yang H; Du EX; Kelkar SS; Winkel C
Am J Obstet Gynecol; 2015 Aug; 213(2):141-60. PubMed ID: 25771213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
